Ross Thomas M.'s Form 4 filing
Maxcyte, Inc. (MXCT) · filed Apr 7, 2023
- Accession no.
- 0001209191-23-023809
- Filed
- Apr 7, 2023
- Trade date
- Apr 5-6, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $171.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ross Thomas M.CIK 0001874572 | Officer (EVP, Global Sales & Marketing) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 5, 2023 | Common Stock | MOption exerciseAcquired | +6,967 | $2.14 | +$14,909.38 | 6,967 | Direct | |
| Apr 5, 2023 | Common Stock | SSaleDisposed | −6,967 | $5.00 | −$34,835 | 0 | Direct | |
| Apr 6, 2023 | Common Stock | MOption exerciseAcquired | +27,193 | $2.14 | +$58,193.02 | 27,193 | Direct | |
| Apr 6, 2023 | Common Stock | SSaleDisposed | −27,193 | $5.03 | −$136,780.79 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 5, 2023 | Common Stock | MOption exerciseDisposed | −6,967 | $0.00 | $0 | 55,195 | Direct | |
| Apr 6, 2023 | Common Stock | MOption exerciseDisposed | −27,193 | $0.00 | $0 | 28,002 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.